R heumatoid arthritis affects millions of people worldwide with reduced quality of life and economic costs. This disease is characterized by chronic inflammation and progressive joint destruction, with debilitating consequences 1 . A hallmark of human rheumatoid arthritis and mouse models of arthritis is the leukocyte influx into the joint synovium, with neutrophils being the most abundant 2 . Activated neutrophils promote chronic inflammation, along with matrix and cartilage degradation 2 . Although effective therapies have been introduced, a significant fraction of rheumatoid arthritis patients are refractory to existing therapies 3 . Genome-wide association studies have identified many genetic loci; however, most of them are single-nucleotide polymorphisms (SNPs) in noncoding genetic regions 4 with no obvious causality. Therefore, better understanding of causative and disease contributing factors is needed.
Cell death via apoptosis occurs during homeostasis and tissue inflammation 5 . While apoptotic cells have been detected in the synovial joints of rheumatoid arthritis patients 6 , resistance to apoptosis has also been implied as a contributory factor to chronic disease; therefore, induction of apoptosis has been proposed as a therapeutic avenue 7 . For these approaches, however, apoptotic cellclearance pathways also need to be considered. Inefficient clearance of apoptotic cells can result in secondary necrosis and exposure of self antigens, and cell-clearance defects are linked to chronic inflammation and autoimmunity 8 .
Apoptotic cells expose 'eat me' signals on their surface that are recognized by specific receptors on phagocytes [9] [10] [11] . Binding of apoptotic cells to phagocyte recognition receptors results in activation of the engulfment machinery, dynamic changes of the actin cytoskeleton, and corpse uptake [9] [10] [11] . Phagocyte receptors can bind phosphatidylserine exposed on the apoptotic cell surface directly (such as TIM-4 (ref. 12 ) and BAI1 (ref. 13 )) or indirectly, through bridging molecules (such as MerTK (ref. 14 ) ), or recognize cell surface modifications or opsonins bound to apoptotic cells 15 . The receptor redundancy and the specific signaling pathways downstream of these engulfment receptors are unclear 16 . One of the better characterized cytoplasmic signaling relays (in both professional phagocytes and nonprofessional phagocytes) is the ELMO-DOCK-Rac signaling pathway 16 . In this mode of signaling, the ELMO-DOCK protein complex acts as a guanine nucleotide-exchange factor to activate the small GTPase Rac, leading to cytoskeletal rearrangements needed for engulfment 17 .
In this work, we examined how components of a specific engulfment pathway may link to inflammatory arthritis. Surprisingly, loss of the engulfment signaling protein ELMO1 alleviated disease severity in mouse models of arthritis through ELMO1's regulation of neutrophil recruitment to inflamed joints. Via proteomic and transcriptomic approaches, we uncover an ELMO1-dependent signature in neutrophils and identify a requirement for ELMO1 in signaling downstream of the receptors for the arthritis-associated Rheumatoid arthritis is characterized by progressive joint inflammation and affects ~1% of the human population. We noted single-nucleotide polymorphisms (SNPs) in the apoptotic cell-engulfment genes ELMO1, DOCK2, and RAC1 linked to rheumatoid arthritis. As ELMO1 promotes cytoskeletal reorganization during engulfment, we hypothesized that ELMO1 loss would worsen inflammatory arthritis. Surprisingly, Elmo1-deficient mice showed reduced joint inflammation in acute and chronic arthritis models. Genetic and cell-biology studies revealed that ELMO1 associates with receptors linked to neutrophil function in arthritis and regulates activation and early neutrophil recruitment to the joints, without general inhibition of inflammatory responses. Further, neutrophils from the peripheral blood of human donors that carry the SNP in ELMO1 associated with arthritis display increased migratory capacity, whereas ELMO1 knockdown reduces human neutrophil migration to chemokines linked to arthritis. These data identify 'noncanonical' roles for ELMO1 as an important cytoplasmic regulator of specific neutrophil receptors and promoter of arthritis.
molecules C5a and LTB4. These data suggest a neutrophil-specific ELMO1-dependent signaling nexus that controls different aspects of arthritis.
Results
Engulfment protein ELMO1 is associated with arthritis. To test whether specific engulfment machinery components are associated with human rheumatoid arthritis, we searched publicly available databases for SNPs. We found multiple SNP-disease associations with human rheumatoid arthritis in ELMO1, as well as in DOCK2 and RAC1 genes (see Methods; Fig. 1a and Supplementary Table 1 ). In a meta-analysis for common SNPs or gene linkages to both rheumatoid arthritis and celiac disease, a SNP in human ELMO1 (rs11984075) was discovered 18 . A previous approach assessing the methylation status of arthritis-associated genes also reported that the ELMO1 locus was hypomethylated in fibroblast-like synoviocytes (FLS) that line the synovium of the joints 19 . ELMO1 functions at the interface between the phagocytic receptors and their downstream cytoplasmic signaling activity, leading to corpse internalization 13, 17, 20, 21 . As apoptotic cell clearance is an anti-inflammatory process, we hypothesized that disruption of ELMO1 might lead to greater joint inflammation.
To test whether expression of specific engulfment machinery components might change during joint inflammation in mice, we initially analyzed the K/BxN mouse model of spontaneous arthritis 22 ( Supplementary Fig. 1a ). K/BxN mice develop progressive joint disease resembling rheumatoid arthritis, including autoantibody production, chronic joint inflammation, and bone erosion 22 . We analyzed mRNA expression of the engulfment receptors Bai1, Bai2, Bai3, Tim4, Mertk, and Cd36, as well as the Elmo, Dock, and Rac family members in the the paw extracts of 9-week-old K/BxN mice. Transcript levels for Elmo1, Rac1, and Rac2 were increased, whereas the expression of engulfment receptors either remained unchanged or was slightly decreased ( Fig. 1b and Supplementary Fig. 1b ). ELMO1 protein was also increased in the paw extracts from mice with spontaneous arthritis (Fig. 1c,d ). Based on this observation and the linkage of ELMO1 SNPs to human rheumatoid arthritis, we addressed the role of ELMO1 further.
Elmo1 -/mice show reduced arthritis severity in two different arthritis models. Transferring serum from arthritic K/BxN mice to healthy mice initiates joint disease in many strains of mice 23 . This K/BxN serum-transfer arthritis is thought to model the effector phase of human arthritis ('inflammatory flare-ups'), due to the transient nature and strict dependence on innate immune system components. Disease induction is rapid, synchronous, and nearly 100% penetrant, with swelling of the paws apparent 1-2 days post K/BxN serum injection 23 . We tested arthritis development after two injections of the K/BxN serum (day 0 and day 2). Extracts from diseased paws of control mice showed increased ELMO1 protein in the joints (Fig. 1e ). We next assessed arthritis in Elmo1 -/mice and their control littermates using paw swelling and other disease parameters to assign clinical scores (see Methods). Elmo1 -/mice are generally healthy when housed under specific pathogen-free conditions 24 . Although arthritis was readily observed and comparable in wildtype and heterozygous Elmo1 +/mice, homozygous Elmo1 -/mice showed significantly milder disease ( Fig. 1f ). Histology of ankle sections (day 10) revealed severe inflammatory cell infiltration in controls that was significantly decreased in Elmo1 -/mice (Fig. 1g ). The reduction in disease severity in Elmo1 -/mice was also observed with a single injection of K/BxN serum and was not sex dependent (data not shown). Since two injections of K/BxN serum induced stronger disease (attenuated by ELMO1 deficiency), we used a twoinjection regimen in the rest of this work.
We also tested whether ELMO1 plays a role in the collagen-induced arthritis (CIA) model that mimics many features of human rheumatoid arthritis 25 and includes involvement of both the innate arm and the adaptive arm of immunity. We backcrossed Elmo1 -/mice to the DBA/1J strain, in which CIA is most consistently seen 25 , and immunized them with collagen (see Methods). Again, increased ELMO1 protein levels were seen in the paws of control mice with CIA ( Fig. 1h ). Although Elmo1 +/+ DBA mice developed signs of arthritis around day 21, with most mice becoming sick by about 40 days following immunization, about a quarter of Elmo1 -/-DBA mice displayed no signs of arthritis throughout the duration of the experiment ( Fig. 1i and Supplementary Fig. 1c,e ). Among those that developed arthritis, Elmo1 -/-DBA mice had delayed onset and lower disease severity compared with that of control mice ( Fig. 1j and Supplementary  Fig. 1d ,f). This difference persisted through the chronic stages of disease in both sexes ( Supplementary Fig. 1c-f ). These data collectively suggest that ELMO1 promotes disease severity in arthritis.
ELMO1 function in neutrophils affects arthritis disease severity.
When we assessed uncleared apoptotic cells in the arthritic joints, many cleaved-caspase-3-positive cells were seen in the control littermates ( Fig. 2a , left and inset). Very few such cells were observed in the Elmo1 -/mice ( Fig. 2a ). Since the fewer apoptotic cells could correlate to reduced inflammation within the joints of Elmo1 -/mice, we focused on the areas of inflammation; even then, there were significantly fewer apoptotic cells ( Fig. 2a , right). This was not due to compensatory upregulation of the homologs Elmo2 and Elmo3 in the Elmo1 -/mice ( Supplementary Fig. 1g ). During apoptotic-cell clearance, ELMO1 binds to the cytoplasmic tail of the phosphatidylserine receptor BAI1 and, via subsequent downstream signaling, promotes corpse engulfment ( Supplementary Fig. 1h ) 13 . Bai1 -/mice developed disease comparable to that of their wild-type littermates in the K/BxN serum-induced arthritis model ( Supplementary Fig. 1i ). These data suggest that the attenuation of arthritis seen in Elmo1 -/mice is likely not linked to cell clearance per se.
We then took a genetic approach to address the cell type(s) in which ELMO1 function was promoting arthritis. Disease development in K/BxN serum-transfer arthritis requires cells of the innate immune system 23 . As ELMO1 protein expression was detected in both macrophages and neutrophils ( Fig. 2b) , we generated mice with conditional deletion of Elmo1 broadly in the myeloid lineage by crossing Elmo1 fl/fl mice 24 with Lyz2-Cre mice 26 . When injected with K/BxN serum, Elmo1 fl/fl Lyz2-Cre mice showed attenuated disease ( Fig. 2c ). Histology at disease maximum also revealed reduced inflammation in the ankle joints of Elmo1 fl/fl Lyz2-Cre mice ( Fig. 2d ) and correlated with ELMO1 protein deletion in myeloid lineage cells ( Supplementary Fig. 2a ). Of note, Lyz2-Cre expression alone (without floxed Elmo1 alleles) does not alter disease development in the K/BxN serum-induced arthritis ( Supplementary Fig. 2b ). Thus, ELMO1 expression in myeloid cells regulates arthritis severity.
In analysis of the inflammatory infiltrate within the paws, fewer CD11b + Ly6G + neutrophils were seen at disease maximum in the global Elmo1 -/mice, as well as in the Elmo1 fl/fl Lyz2-Cre mice ( Fig. 2e and Supplementary Fig. 2c,d) . To test the importance of ELMO1 expression in neutrophils versus macrophage/monocytic lineages, we crossed Elmo1 fl/fl mice with either Mrp8-Cre mice, to delete Elmo1 expression primarily in neutrophils 27 , or with Cx3cr1-Cre mice, which targets mainly monocytes and macrophages 28 . Elmo1 fl/fl Cx3cr1-Cre mice developed disease comparable to that of their wild-type littermates after K/BxN serum injection ( Fig. 2f and Supplementary Fig. 2e ,f), despite decreased ELMO1 protein in the macrophage lineage ( Fig. 2g ). In contrast, deletion of Elmo1 in neutrophils in the Elmo1 fl/fl Mrp8-Cre mice led to reduced disease ( Fig. 2h and Supplementary Fig. 2g ). Histology of ankle joints showed reduced inflammatory cell infiltration in Elmo1 fl/fl Mrp8-Cre mice (Fig. 2i ). ELMO1 deletion in neutrophils from Elmo1 fl/fl Mrp8-Cre mice was verified by immunoblotting of purified Ly6G + cells ( Supplementary Fig. 2h ). Mrp8-Cre alone does not affect disease Elmo1 severity ( Supplementary Fig. 2i and data not shown). Although ELMO1 expression was previously reported in FLS 19 , even in control mice, ELMO1 protein was barely detectable in the FLS (compared with the strong expression in neutrophils) ( Supplementary  Fig. 2j ). Thus, reduced arthritis induction in Elmo1 fl/fl Mrp8-Cre mice phenocopies the global Elmo1 -/mice (Figs. 2h and 1g).
To address whether ELMO1 functions as a broad inhibitor of inflammation, we tested several models in which inflammation is associated with neutrophil infiltration. First, we challenged Elmo1 +/+ and Elmo1 -/mice with intranasal administration of lipopolysaccharide (LPS) and monitored the recruitment of neutrophils to the lung ( Supplementary Fig. 3a ). Eight hours post-LPS administration, recruitment of neutrophils was detected in the bronchoalveolar lavage of control mice and was not significantly altered in Elmo1 -/mice ( Supplementary Fig. 3b ). Second, to test a bacterial infection in vivo, we subjected Elmo1 +/+ and Elmo1 -/mice to fecalinduced peritonitis, a model of septic shock 29 , and assessed neutrophil recruitment into the infected peritoneum, as well as clinical parameters of disease development and survival ( Supplementary  Fig. 3c ). Four hours after induction of fecal-induced peritonitis, Elmo1 -/mice had neutrophil infiltration to the site of infection comparable to that of control mice ( Supplementary Fig. 3d ). The transient temperature drop, clinical scores, and survival did not differ between Elmo1 +/+ mice and Elmo1 -/mice ( Supplementary  Fig. 3e -g). Additionally, purified Elmo1 -/neutrophils showed comparable ability to kill the bacterial pathogen Klebsiella pneumoniae, clearance of which potently depends on neutrophil function 30 ( Supplementary Fig. 3h ). Third, as Elmo1 -/mice do not exhibit signs associated with autoimmunity under specific pathogen-free conditions, we tested them in experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis that involves adaptive immunity and neutrophil function 31 . Elmo1 -/mice developed EAE symptoms comparable to those of control animals, with similar demyelination ( Supplementary Fig. 3i ,j and data not shown). These data suggest that ELMO1 deficiency does not generally impair inflammation and that there is likely a specificity associated with ELMO1 loss in neutrophils and attenuation of arthritis signs.
ELMO1 regulates neutrophil chemotaxis to inflamed joints.
To better understand the differences in arthritis severity due to ELMO1 deletion in neutrophils versus macrophages, and to help decipher how ELMO1 might affect neutrophil function during arthritis, we assessed the ELMO1 protein interactome. We purified Ly6G + neutrophils from the bone marrow and resident peritoneal macrophages from Elmo1 +/+ and Elmo1 -/mice and performed ELMO1 immunoprecipitation, followed by liquid chromatography-mass spectrometry and proteomics analysis ( Fig. 3a) . Comparison of the proteomics results between Elmo1 +/+ mice and Elmo1 -/mice helped identify ELMO1-specific protein partners (direct or indirect interaction with ELMO1). Further analysis of ELMO1 protein interactomes in neutrophils versus macrophages (see Methods) helped identify the neutrophil-specific ELMO1 protein-interaction network composed of 30 proteins ( Fig. 3b and Supplementary Table 2 ). The neutrophil-specific ELMO1 protein interactome was analyzed by STRING (https://string-db.org) to reveal protein-protein connections 32 . The known ELMO1 partners DOCK and RAC were added to provide context ( Fig. 3b , blue), although theseproteins were present in ELMO1 interactomes of both cell types. The newly identified neutrophil-specific ELMO1 partners have a range of distinct functions, and several have known associations with human arthritis ( Fig. 3c ; see Methods for arthritis linkage references).
Interestingly, several of the neutrophil-specific ELMO1 protein partners are linked to cell migration (Fig. 3b,c) , Initial neutrophil recruitment into the synovium during arthritis is mediated by leukotriene B4 (LTB4) and is further sustained by CXCR2 agonists such as CXCL1 (ref. 33 ). As ELMO1 has also been linked to gradient-dependent migration 20,21 , we examined migration of purified neutrophils from wild-type and ELMO1-deficient mice in a Transwell migration assay. Elmo1 -/neutrophils (either purified or in the context of total bone marrow) showed significantly reduced migration toward LTB4 and CXCL1 ( Fig. 3d and Supplementary  Fig. 4a ). To visualize the linkage between ELMO1 expression and neutrophil migration in vivo, we used two-photon microscopy to analyze neutrophil swarming toward the site of laser-induced injury in the mouse ear (which is also LTB4 dependent 34 ). Compared with the increased and directed migration toward the site of injury of control neutrophils, Elmo1 -/neutrophils showed defective migration to the injury site and did not increase the speed of movement (Fig. 3e,f and Supplementary Videos 1 and 2).
Since neutrophil migration into the joint synovium is a hallmark of acute inflammatory episodes in human rheumatoid arthritis, we asked whether ELMO1 might affect neutrophil migration to the joints. Elmo1 +/and Elmo1 -/mice were injected with K/BxN serum, and neutrophil infiltration into the joints 24 h later was imaged via IVIS scanning by the luminescent signal that arises from the myeloperoxidase-mediated conversion of injected luminol 35 . Compared with control animals, Elmo1 -/mice had much reduced luminescence in the joints (Fig. 4a ). This was not due to altered expression of the receptors for the chemokines LTB4 or CXCL1, as Elmo1 -/neutrophils had expression of transcripts encoding the LTB4 receptor (Blt1) comparable to that of Elmo1 +/+ cells ( Supplementary Fig. 4b ), and the protein levels of the CXCL1 receptor CXCR2 were unchanged on the surface of neutrophils in both blood and bone marrow ( Supplementary Fig. 4c ).
ELMO1 acts in the signaling relay between chemokine receptors and neutrophil activation/migration. The above data demonstrated that ELMO1 regulates neutrophil migration in vitro and in vivo and in response to chemokines linked to arthritis. As neutrophil migration to other inflammatory stimuli (such as LPS stimulation or bacterial infection) was not affected by loss of ELMO1, one possible mechanistic explanation was that ELMO1 might function downstream of receptor(s) for arthritis-linked chemokines. Our proteomics data (Fig. 3b ,c) identified two ELMO1-binding membrane proteins that have been shown to function in inflamed joints: C5aR1 (CD88), receptor for the complement component C5a (also called anaphylatoxin), and the integrin CD11b (Itgam) 36, 37 (Fig. 3b, yellow) .
C5a-C5aR1 is referred to as a 'master switch' in neutrophil recruitment that drives establishment of clinical signs of disease in arthritis [38] [39] [40] . Of note, C5a-C5aR1 signaling does not appear to regulate disease phenotypes in EAE or LPS challenge models 41, 42 , which we also found are not influenced by ELMO1 deficiency ( Supplementary Fig. 3 ). In arthritis, C5aR1 ligation is uniquely required for initial neutrophil adhesion to the endothelium and firm arrest and is mediated via upregulation of integrins on the neutrophil surface, such as CD11b (our second ELMO1 binding partner of interest) 43 . CD11b is also a neutrophil activation marker that is upregulated by different stimuli to regulate migration, including LTB4-dependent neutrophil swarming 34 . We asked whether CD11b cell-surface exposure induced by neutrophil activation with C5a or LTB4 would be altered due to ELMO1 deficiency (Fig. 4b ). CD11b levels on wild-type neutrophils were strongly increased by C5a or LTB4 stimulation ( Fig. 4c,d ), and this was significantly stunted in Elmo1 -/neutrophils ( Fig. 4d ). This suggested that ELMO1 functions in a signaling relay (that is, inside-out signaling) between neutrophil activation and CD11b integrin-mediated cell adhesion. As control, we did not observe differences in LTB4 or C5a receptor expression or ligand-dependent C5aR1 internalization in Elmo1 -/neutrophils ( Fig. 4e and Supplementary Fig. 4b ). We then asked whether CD11b is required for neutrophil migration in response to LTB4. Blocking CD11b function with a neutralizing antibody reduced neutrophil migration to the levels observed in Elmo1 -/cells ( Fig. 4f ), suggesting that ELMO1's regulation of neutrophil migration to LTB4 is in part dependent on CD11b. ELMO1-deficient neutrophils were not inherently deficient in CD11b upregulation, as bypassing receptormediated activation by a strong intracellular stimulus such as the phorbol ester PMA resulted in a comparable increase in CD11b in Elmo1 +/+ neutrophils and Elmo1 -/neutrophils ( Fig. 4g ).
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Meandering index : Injury Track velocity (µm s -1 ) + -+ - from control or Elmo1 -/mice (even at high LPS concentrations) ( Fig. 4g ). We also examined CD11b induction with aggregated IgG (to mimic immunocomplexes), and found that CD11b was comparably upregulated in wild-type and Elmo1 -/neutrophils ( Fig. 4h ). Immunocomplex-mediated neutrophil degranulation and release of chemotactic factors was also not impaired by ELMO1 Elmo1 deficiency, as determined by the migration of wild-type neutrophils to the chemotactic mediators present in the supernatants from IgGactivated Elmo1 -/neutrophils ( Fig. 4i ). It is worth noting that in Elmo1 -/neutrophils from blood and bone marrow, we found no alterations in the surface levels of neutrophil receptors Fcγ RIII and Fcγ RIV (refs. 35, 38, 44 ) or in the protein tyrosine kinase Syk required for Fcγ receptor signaling 45 ( Supplementary Fig. 4d-f ). Together, these data suggest that ELMO1 is part of the signaling relay that occurs between specific arthritis-associated chemokines (such as C5a and LTB4) and the neutrophil activation marker CD11b linked to neutrophil migration.
Induced deletion of Elmo1 after disease onset reduces arthritis severity.
To test whether deletion of Elmo1 after the induction of arthritis can alleviate disease parameters, we crossed Elmo1 fl/fl mice with Ubc-Cre ERt2 mice, in which Cre recombinase is expressed ubiquitously; however, Cre stays functionally inactive due to its fusion with an ER domain until the administration of tamoxifen, which can be done in adult mice at the desired time 46 . After verifying that Elmo1 deletion in Elmo1 fl/fl Ubc-Cre ERt2 mice does not occur before tamoxifen administration (data not shown), we first induced arthritis in Elmo1 fl/fl Ubc-Cre ERt2 mice and littermate controls by injection of K/BxN serum on days 0 and 2 (Fig. 4j ). Starting on day 3, we administered tamoxifen (see Methods) to induce Elmo1 deletion and then monitored disease parameters. Tamoxifen administration in arthritic Elmo1 fl/fl Ubc-Cre ERt2 mice resulted in the rapid arrest of further disease development and enhanced recovery in both sexes ( Fig. 4k and Supplementary Fig. 5a ), compared with that of tamoxifen-treated control mice. Since only a partial loss of ELMO1 protein was observed in peritoneal and bone marrow cells from Elmo1 fl/fl Ubc-Cre ERt2 mice (Fig. 4l ), this suggests that even partial reduction in ELMO1 during acute phases of arthritis could be of benefit. Importantly, Elmo1 fl/fl Ubc-Cre ERt2 mice did not have reduced disease when tamoxifen was not administered and deletion of Elmo1 was not induced ( Supplementary Fig. 5b ). We also deleted Elmo1 during the peak of K/BxN serum-inducedarthritis, after neutrophil mobilization had already occurred ( Supplementary Fig. 5c ). When induced by this 'late' regimen, loss of ELMO1 did not significantly improve signs of disease ( Supplementary Fig. 5d ), supporting the critical role for ELMO1 in the early recruitment of neutrophils to the joint.
Elmo1 regulates cell type-specific transcriptional programs.
Since Rac1, which functions downstream of ELMO1, can regulate gene transcription, we next tested whether ELMO1 modulates transcriptional networks by RNA-sequencing analysis of cells with or without ELMO1. We also compared the transcriptomes of neutrophils and macrophages to identify neutrophil-specific ELMO1dependent transcriptional signatures (Fig. 5a ). In both cell types, modulators of actin cytoskeleton dynamics and cell adhesion and/or migration were regulated by Elmo1 ( Supplementary Table 3 ). However, we noted a clear difference in the prominent classes of functionally related transcripts between neutrophils and macrophages. There was an overall paucity of shared genes and transcriptional programs regulated by Elmo1, suggesting a previously unappreciated cellular specificity in Elmo1-dependent gene networks. Elmo1-regulated transcriptomes in neutrophils and macrophages overlapped by only ten genes (including Elmo1 itself) ( Fig. 5b and Supplementary Table 3 ). We found that Elmo1 deficiency in neutrophils was associated with decreased expression of arthritis-promoting factors and increased expression of protective modulators (Fig. 5c,d) , with many of the Elmo1-dependent neutrophil-specific genes previously linked to arthritis disease progression ( Fig. 5b-d ; see Methods for arthritis linkage references). Moreover, neutrophils lacking ELMO1 exhibited an anti-inflammatory signature ( Fig. 5b and Supplementary Table 3 ), exemplified by marked upregulation of the gene Tnfaip1 (encoding A20, a potent inhibitor of inflammatory signaling and arthritis in mice) 47 . Collectively, these data suggest that Elmo1 could modulate neutrophil function in inflammatory arthritis via mechanisms beyond the regulation of migration.
ELMO1 SNP rs11984075 alters neutrophil migration. Within the human ELMO1 locus, we found multiple SNPs correlating with diabetic nephropathy, IgG glycosylation, celiac disease, and psoriasis, in addition to rheumatoid arthritis (Fig. 6a ). Although none of the rheumatoid arthritis-associated SNPs in ELMO1 are known to cause changes in mRNA or protein expression, Elmo1 levels were altered in a mouse model of diabetic nephropathy 48 . ELMO1 protein expression is readily detected in human peripheral blood neutrophils ( Supplementary Fig. 5e ). To test whether the presence of SNPs in ELMO1 linked to rheumatoid arthritis alter ELMO1 protein levels and neutrophil functions, we screened 15 healthy blood donors for ELMO1 rs11984075 and ELMO1 rs10488029 (see Supplementary  Table 1 ). Two of the fifteen donors were heterozygous for ELMO1 rs11984075 (Fig. 6b ), whereas none had ELMO1 rs10488029 (not shown). ELMO1 protein expression in neutrophils from the two ELMO1 rs11984075 donors was elevated ~20% compared with controls ( Fig. 6c ), suggesting that this intronic mutation could have additional effects on gene expression 49 . Indeed, neutrophils from the two ELMO1 rs11984075 donors displayed increased migration toward LTB4 in a Transwell assay ( Fig. 6d ) and had higher l-selectin (CD62L), a leukocyte receptor that mediates early stage adhesion to the vascular endothelium during neutrophil extravasation and contributes to arthritis development 50 (Fig. 6e ). This was particularly interesting, as CD62L on the surface of circulating neutrophils in Elmo1 -/mice was significantly reduced (Fig. 6f ), suggesting an additional avenue for ELMO1's regulation of neutrophil recruitment. Since the bone marrow neutrophils from Elmo1 -/mice had comparable levels of CD62L (Fig. 6g ), loss of ELMO1 likely regulates this adhesion molecule in fully matured neutrophils.
As a corollary to this 'gain of function' in migration with rs11984075, we tested whether loss of ELMO1 in human neutrophils might affect their migration to arthritis-associated chemokines. Since ELMO1 depletion in primary human neutrophils is not feasible (due to their short life span), we utilized the human neutrophil cell line HL-60 with knockdown of ELMO1 expression. ELMO1-deficient HL-60 cells (Fig. 6h ) differentiated into neutrophils exhibited reduced migration to LTB4 compared with controls ( Fig. 6i) . Collectively, these observations demonstrate that ELMO1 modulates human neutrophil chemotaxis to soluble mediators linked to arthritis.
Discussion
Although a few recent biologics targeting specific inflammatory components have revolutionized the control of arthritis symptoms, they have been effective in only a subset of patients 3 . This work, based on several lines of evidence, identifes the ELMO1-dependent molecular signaling nexus with potential new targets for therapeutic intervention. First, the enhanced expression of ELMO1 protein and enhanced migration of neutrophils from healthy donors carrying the SNP rs11984075 imply a key linkage of SNPs in ELMO1 to human arthritis at a functional and genetic level. Although this clearly needs to be further validated, screening for such SNPs could be a potential biomarker for arthritis susceptibility. Second, based on K/BxN serum-transfer and CIA models, ELMO1 can affect both acute phases and chronic phases of the disease. Third, many of the genes and proteins regulated in an ELMO1-dependent manner in neutrophils are genetically linked to human arthritis (via SNPs, altered expression, or biomarker status) or are functionally linked to experimental arthritis. Fourth, as deletion of ELMO1 after arthritis initiation could decrease signs of disease in Elmo1 fl/fl Ubc-Cre ERt2 mice, targeting ELMO1 in ongoing human arthritis may be of benefit. As our data suggest that ELMO1 deficiency does not impair neutrophil response to bacterial challenge, targeting ELMO1 function may not indiscriminately suppress the immune system.
Interestingly, in the transcriptomics of neutrophils and macrophages, only ten core genes were commonly regulated in both cell types due to ELMO1. This goes against the 'general assumption' that the same genes/proteins likely perform similar functions in different cell types, especially those within the myeloid lineage. Thus, the potential benefit of targeting common pathways in specific instances needs to be explored.
Much of the literature suggests that the apoptotic cell-clearance process is generally anti-inflammatory. The data here advance a concept that evolutionarily conserved apoptotic cell-engulfment machinery components can have both canonical roles and noncanonical roles in inflammation, depending on the cell type and context. Since induction of apoptosis in rheumatoid tissues has been proposed as a potential therapeutic approach 7 , consideration of noncanonical and less expected roles of engulfment proteins is warranted.
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Methods
Mice. C57BL/6J, DBA/1J, NOD, Mrp8-Cre, Cx3cr1-Cre, Lyz2-Cre, and Ubc-Cre ERt2 mice were obtained from Jackson Laboratories. Elmo1 fl/fl and Elmo1 -/mice have been described previously 24 . To generate mice with deletion of Elmo1 in myeloid cells, neutrophils or macrophages, Elmo1 fl/fl mice were crossed to Lyz2-Cre, Mrp8-Cre, or Cx3cr1-Cre mice, respectively. To generate mice with inducible deletion of Elmo1, Elmo1 fl/fl mice were crossed to Ubc-Cre ERt2 . In these mice, Elmo1 deletion was induced by three daily intraperitoneal injections of 40 mg kg -1 tamoxifen dissolved in corn oil. To generate Elmo1 -/-DBA mice, Elmo1 -/mice were backcrossed onto the DBA/1J background for at least five generations. KRN TCR transgenic mice 22 were a gift from D. Mathis at the Harvard Medical School and were bred to NOD mice to obtain the K/BxN mice 23 , which develop progressive spontaneous arthritis. K/BxN serum was collected from 9-week-old K/BxN mice by cardiac puncture. Age-and sex-matched littermate control animals were used for all experiments, and both males and females were assessed. In Elmo1 fl/fl Lyz2-Cre mice, reduced disease severity was observed in female mice but not in male mice (data not shown). All animal procedures were approved by and performed according to guidelines of the Institutional Animal Care and Use Committee at the University of Virginia.
K/BxN serum transfer-induced arthritis.
Mice were injected with 150 μ l of serum from K/BxN mice on day 0 (one dose K/BxN) or on days 0 and 2 (two dose K/BxN). In experiments with inducible deletion of Elmo1, tamoxifen was administered on days 3, 4, and 5. Paw swelling was measured at indicated time points using a caliper (Fisher). Clinical scores were assigned for each paw as follows: 0, no paw swelling or redness observed; 1, redness of the paw or a single digit swollen, normal V shape of the hind foot (the foot at the base of the toes is wider than the heel and ankle); 2, two or more digits swollen or visible swelling of the paw, U shape of the hind foot (the ankle and the midfoot are equal in thickness); 3, reversal of the V shape of the hind foot into an hourglass shape (the foot is wider at the heel than at the base of the toes). A combined clinical score of all paws is presented. Scores were assigned by an investigator blinded to the mouse genotypes.
Collagen-induced arthritis. Elmo1 -/mice and wild-type controls in the DBA background were immunized at the base of the tail by intradermal injection of a 1:1 solution of 10 mM acetic acid containing 100 μ g of bovine collagen-II and Complete Freund's Adjuvant (Sigma) containing 100 μ g of heat-killed Mycobacterium tuberculosis H37Ra (BD). Mice received a booster immunization on day 21. Paw swelling was measured at indicated time points using a caliper. Clinical scores were assigned for each paw as follows: 0, no paw swelling or redness observed; 1, redness of the paw or a single digit swollen; 2, two or more digits swollen or visible swelling of the paw; 3, visible swelling of the ankle; 4, ankylosis of the joint. A combined clinical score of all paws is presented. Scores were assigned by an investigator blinded to the mouse genotypes.
Experimental autoimmune encephalomyelitis. EAE was induced in female mice (8 to 12 weeks) by subcutaneous injection of MOG peptide (100 μ g, CSBio) emulsified in complete Freund's adjuvant. Pertussis toxin (250 ng, List Biologicals) was administered intraperitoneally on the day of and one day after MOG immunization. For clinical evaluation, mice were scored daily according to the following criteria: 0, no clinical disease; 1, limp tail; 2, hind limb weakness; 3, hind limb paralysis; 4, hind limb paralysis and partial front limb paralysis; 5, moribund. Scores were assigned by an investigator blinded to the mouse genotypes.
Histology. For K/BxN serum transfer-induced arthritis, mice were euthanized at the indicated time points and the paws were fixed in 10% formalin (Fisher). Decalcification, sectioning, paraffin embedding, and hematoxylin and eosin (H&E) staining was performed by HistoTox Labs. Histology scoring was performed by an investigator blinded to the mouse genotypes. For inflammation scoring, the following criteria were used: 0, none; 1, mild; 2, moderate; 3, severe. For boneerosion scoring, the following criteria were used: 0, no bone erosions observed; 1, mild cortical bone erosion; 2, severe cortical bone erosion without the loss of bone integrity; 3, severe cortical bone erosion with the loss of cortical bone integrity and trabecular bone erosion. Cleaved caspase-3 staining was performed at the University of Virginia Biorepository and Tissue Research Facility. For RNA and protein isolation, the paws were snap frozen in liquid nitrogen at indicated time points and subjected to mechanical disruption using a tissue pulverizer (Spectrum Laboratories). For EAE experiments, spinal cords were isolated on day 26 after immunization and paraffin embedded, and 4 μ m sections were cut, stained with Luxol Fast Blue, and counterstained with hematoxylin following standard protocols. Extent of demyelination (loss of blue staining) in the white matter of the spinal cord was measured at four different levels of the spinal cord.
Flow cytometry of arthritic joints. Mice were injected with the K/BxN serum on day 0 and day 2, as described above. On day 10, mice were euthanized and the skin removed from the hind paws. Ankle tendons were cut and the foot was detached from the tibia and placed in DMEM containing 20 units ml -1 of collagenase IV (Roche). The soft tissue was cut with a scalpel and the joints opened by gentle pulling of the foot bones. The paws were incubated for 2 h at 37 °C with periodic trituration. Liberated cells were collected, strained though a 70 μ m filter (Fisher), washed with DMEM, counted and subjected to flow cytometry on Canto I flow cytometer using 7-aminoactinomycin D (7-AAD) to identify live cells, as well as anti-CD45 (eBioscience clone 30-F11), anti-CD11b (eBioscience clone M1/70), and anti-Ly6G (clone 1A8, BD Pharmingen).
Neutrophil isolation, stimulation, and in vitro migration. Femurs were removed from 6-to 8-week-old mice, flushed with sterile serum-free α -MEM and single cell suspensions were prepared using the 70 μ m cell strainer. Cells were incubated with anti-Ly6G (clone 1A8, BD Pharmingen) and purified using the anti-PE MACS kit (Myltenyi), following the manufacturer's instructions. Purified neutrophils (Ly6G + ) were seeded in 96-well tissue culture U-bottom plates (10 6 cells per well) and stimulated with 100 ng ml -1 mouse C5a (R&D Systems), 1-10 nM LTB4, 50 ng ml -1 PMA (Calbiochem) or 0.5-10 μ g ml -1 LPS (Escherichia coli 0111:B4, Sigma). Alternatively, high-binding 96-well plates (Greiner Bio-One) were coated with 50 μ g ml -1 of mouse IgG (Southern Biotech) in PBS for 16 h at 4 °C, washed with PBS and purified neutrophils were seeded as above to induce Fcγ R-mediated neutrophil stimulation. Cells were stimulated for 1 h at 37 °C, and the cells were then washed and stained with antibodies specific for CD11b or CD88/ C5aR1 (eBioscience clone S5/1) and subjected to flow cytometry analysis on the FACSCanto I (BD Bioscience) or the Attune Nxt (Thermo Fisher) flow cytometer.
In some experiments, supernatants from cells stimulated with IgG were collected by centrifugation and removal of cell pellets and used for migration, as described below. For migration experiments, total bone marrow (2 × 10 6 cells per well) or purified Ly6G + bone marrow cells (0.2 × 10 6 to 0.5 × 10 6 cells per well) were seeded in top chambers of 3 μ m polycarbonate Transwell plates (Corning) in 100 μ l of HBSS (with calcium and magnesium, no phenol red, Gibco) containing 1% bovine serum albumin (Roche). Bottom chambers contained 600 μ l of media without (control) or with the indicated concentrations of leukotriene B4 (LTB4, Tocris Bioscience) or CXCL1 (BioLegend) or undiluted supernatants from IgG-stimulated neutrophils. After 3 h at 37 °C, the cells in the bottom wells were collected and subjected to flow cytometry analysis with counting beads (Spherotech). The data are presented as percent of input cells. Alternatively, bone marrow neutrophils were isolated using the EasySep Mouse Neutrophil Enrichment Kit according to the manufacturer's instructions (StemCell Technologies). For some experiments, peripheral blood cells and the bone marrow cells were stained for flow cytometry with anti-Ly6G (clone 1A8, BD Pharmingen), anti-CD11b (eBioscience clone M1/70), anti-CD62L (eBioscience clone MEL-14), anti-CXCR2 (BioLegend clone SA045E1), anti-FcgRIII (R&D Systems clone no. 275003), or anti-Fcγ RIV (Sino Biological, clone no. 012) or for immunoblot with anti-FcgRI (Santa Cruz sc-7642) or anti-Syk (Santa Cruz sc-1077).
Intravital imaging of neutrophil motility. To visualize migration of neutrophils, intravital imaging was performed using FV1000-AOM multiphoton system (Olympus) equipped with a × 25 NA1.05 water immersion objective. For twophoton excitation, a Mai-Tai HP Ti:Sa Deep See laser system (Spectra-Physics) was tuned to 900 nm for imaging. Neutrophils labeled with CellTracker Green CMFDA (Thermo Fisher Scientific) were intradermally injected into ear skin 2 h before in vivo imaging. Mice were anesthetized by intraperitoneal injection of pentobarbital (Nembutal sodium solution, Oak Pharmaceuticals), and anesthetic condition was maintained using isoflurane. Hair of the mouse ear was removed using a commercial hair remover (Nair). The anesthetized mice were laid in a ventral recumbent position on a custom-designed stage to expose the dorsal side of the ear pinna for imaging. Micropore (3M Health Care) tapes were placed to immobilize the ear skin. Body temperature of the mice was controlled with heat pad and the ear immersed in a drop of glycerol/saline (40:60 v/v) and covered with a coverslip. Laser injury was induced by focusing the multiphoton laser tuned to 800 nm at a region within the ear dermis for 5 s. To track and analyze the movements of the neutrophils, Volocity software (Improvision/PerkinElmer) and ImageJ (National Institutes of Health) were used. LPS challenge and bacterial killing. Elmo1 +/+ , Elmo1 -/-, Elmo1 fl/fl , and Elmo1 fl/fl Mrp8-Cre mice were anesthetized with isoflurane, and 20 μ g of LPS was administered intranasally in a 50 μ l volume. Eight hours later, mice were euthanized by anesthetic overdose. Post-euthanasia, an incision was made in the trachea and the bronchoalveolar spaces were lavaged with 750-1,000 μ l of PBS. The bronchoalveolar lavage fluid was subjected to flow cytometry using 7-AAD (BD Bioscience), anti-Ly6G-APC (eBioscience clone 1A8), anti-Ly6C-FITC (BD Biosciences clone AL-21), and anti-CD11b-PE-Cy7 (eBioscience clone M1/70). Data were analyzed on the Canto I (BD) or the Attune Nxt (Thermo Fisher) flow cytometer. Counting beads (Spherotech ACBP-50-10) were used to calculate the absolute number of neutrophils in the bronchoalveolar lavage fluid. For neutrophil-mediated bacterial killing assays, neutrophils from Elmo1 +/+ and Elmo1 -/mice were purified from the bone marrow using anti-Ly6G, as described above. Klebsiella pneumoniae strain 43816 (ATCC) was opsonized with heat-inactivated, sterile FBS for 30 min at 37 °C. Bacteria were washed twice, and 200,000 bacteria were added to 100,000 purified neutrophils in a 96-well tissue culture plate for 1 h at 37 °C. In some wells, extracellular bacteria were killed by 1 μ g ml -1 of gentamicin for 10 min at 37 °C. Number of surviving bacteria was determined by hypotonic lysis of neutrophils in cold water and serial dilution and culture on blood agar plates.
Fecal-induced peritonitis (FIP).
Fecal material was isolated from the cecum of donor wild-type mice, resuspended in saline, and passed through a 70 µ M strainer to remove large particles. 8-week-old male Elmo1 +/+ and Elmo1 -/mice were intraperitoneally injected with a dose lethal to 50% of animals tested of 1.5 mg fecal content per g mouse weight 29, 51 . Core body temperature was measured using a MicroTherma 2T handheld thermometer (Braintree Scientific, TW2-107), and mice were scored for clinical signs according to a published murine sepsis severity scale 51 . Some mice were euthanized 4 h after FIP induction, and peritoneal cells were flushed out with PBS containing 5% FBS. Cells were stained with Fixable Yellow (to identify viable cells, Thermo Fisher) and anti-Ly6G (eBioscience clone 1A8) and subjected to flow cytometry on the Attune Nxt flow cytometer (Thermo Fisher).
Human peripheral blood neutrophils. Human neutrophils were kindly provided by A. Criss and A. Smirnov (University of Virginia). Materials used in this study were considered discarded materials from other studies and were exempt from human subjects oversight. Briefly, neutrophils were collected from venous blood of de-identified healthy human donors using dextran sedimentation followed by Ficoll gradient sedimentation and hypotonic lysis as described 52, 53 . Buffy coats were also collected and consist of the non-granulocytic cells collected from the Ficoll gradient. Genomic DNA from purified neutrophils was prepared using the MagMax DNA kit (Applied Biosystems), and the status of the ELMO1 rs11984075 SNP was determined using the TaqMan SNP genotyping assay (Applied Biosystems), following the manufacturer's instructions. For Transwell migration assays, 5 × 10 5 cells were seeded in top chambers of 3 μ m polycarbonate Transwell plates in 100 μ l of HBSS containing 1% bovine serum albumin, as described for mouse neutrophils. Bottom chambers contained 600 μ l of 15 nM leukotriene B4. After 2 h at 37 °C, the cells in the bottom wells were collected and subjected to flow cytometry analysis with counting beads (Spherotech), TO-PRO-3 iodide (to identify viable cells, Life Technologies), anti-CD16 (eBioscience clone 3G8), anti-CD11b (BD Pharmingen), and anti-CD62L (BioLegend clone DREG-56) on a FACSCanto I flow cytometer (BD Bioscience). The data are presented as percent of input cells.
Analysis of human HL-60 cells. HL-60 cell line (ATCC) was grown in IMDM containing 20% FBS (Gemini Bio-Products) and 1% penicillin/streptomycin/ glutamine (Gemini Bio-Products) and was routinely tested negative for Mycoplasma contamination. For differentiation into neutrophil-like cells, HL-60 cells were treated with 1.25% DMSO (Sigma) for 4 d (ref. 54 ) and then were cultured without DMSO for 16 h. For generating Elmo1-knockdown cells, HL-60 cells were transfected with 10 μ g of human Elmo1-targeting or control short hairpin RNA (shRNA) pGFP-V-RS expression vectors (OriGene Technologies) bby electroporation using a 250 V, 25 ms pulse. After 24 h, stably transfected cells were selected with 0.2 μ g ml -1 puromycin (Gibco), and single-cell cloning was performed by serial dilution. A total of three control and four Elmo1 shRNA clones were analyzed. Differentiated cells (1 × 10 5 cells per well) were seeded in top chambers of 3 μ m polycarbonate Transwell plates in 100 μ l of HBSS containing 1% bovine serum albumin, as described for neutrophils. Bottom chambers contained 600 μ l of 100 nM leukotriene B4. After 1 h at 37 °C, the cells in the bottom wells were collected and subjected to flow cytometry analysis, as described above. The data are presented as percent of input cells.
Macrophage cultures.
For resident peritoneal macrophage preparation, peritoneal cells were flushed out with PBS containing 5% FBS. Collected cells were spun down, resuspended in XVIVO-10 (Lonza) containing 1% penicillin/streptomycin/glutamine and cultured on tissue culture dishes at 37 °C and 5% carbon dioxide for 16 h. For bone marrow-derived macrophage cultures, femurs were removed from 6-to 8-weekold mice and flushed with sterile serum-free α -MEM (Corning), and single-cell suspensions were prepared using the 70μ m cell strainer (Fisher). Cells were cultured on Petri dishes in α -MEM containing 10% FBS and 1% penicillin/streptomycin/ glutamine with added 10% L929 cell (ATCC) conditioned media as a source of macrophage-colony stimulating factor at 37 °C and 5% carbon dioxide for 7 d.
Fibroblast-like synoviocytes. FLS were prepared following established protocols 55 . Briefly, skin was removed from the hind paws of euthanized 6-to 8-week-old mice, the tendons of the ankles were cut and the paws were dislodged from the tibias and placed into DMEM containing 1 mg ml -1 of collagenase IV, 10% FBS, and 1% penicillin/streptomycin/glutamine. The joints of the foot were opened using gentle pulling of the foot bones. After a 1 h incubation at 37 °C, the liberated cells were collected, strained though a 70 μ m filter (Fisher), and washed with DMEM containing 10% FBS and 1% penicillin/streptomycin/glutamine. The cells were seeded into 10 cm tissue culture coated dishes and were cultured at 37 °C and 5% CO 2 . Media was exchanged every 3 d, and the cells were passaged using 0.25 % trypsin with 2.21 mM EDTA at near confluency. Cells were used for experiments after three passages. Culture purity was confirmed by flow cytometry analysis using anti-CD90.2 (eBioscience clone 53-2.1), anti-VCAM1 (eBioscience clone 429), and anti-CD11b (eBioscience clone M1/70). FLS had the spindle-like shape of fibroblasts and were CD90.2 + VCAM1 + CD11b -.
Microscopy. All images were taken on an EVOS FL Auto (Fisher) and were analyzed using the accompanying software.
Quantitative PCR with reverse transcription. Total RNA was isolated from cultured cells or pulverized paws using the RNA Easy kit (Qiagen) and complementary DNA prepared using the QuantiTect kit (Qiagen) according to the manufacturer's instructions. Quantitative gene expression for target and housekeeping genes was done using Taqman probes (Applied Biosystems) run on a StepOnePlus Real Time PCR System (Applied Biosystems).
Immunoblotting. Protein extracts were prepared from cultured cells or pulverized paws using RIPA lysis buffer with added protease inhibitor cocktail (Calbiochem), 1 mM phenylmethylsulfonyl fluoride (PMSF, Sigma), and 1 mM sodium orthovanadate (Sigma). Equal numbers of purified human neutrophils and buffy coat cells were directly lysed in SDS-PAGE sample buffer containing protease inhibitors cocktail, PMSF, sodium orthovanadate, and 100 mM dithiothreitol. Equal amounts of protein extract were loaded on TGX Precast gels (Bio-Rad), subjected to SDS-PAGE and transferred onto PVDF membranes using the Trans-Blot Turbo transfer system (Bio-Rad). Immunoblotting was performed using anti-ELMO1 rabbit polyclonal antibody 17 , or anti-ERK2 (Santa Cruz, goat polyclonal), anti-GAPDH-HRP (Sigma clone GAPDH-71.1) or anti-beta-ACTIN-HRP (Sigma clone AC-15) as a loading control. Blots were exposed using the Western Lightning Plus ECL kit (PerkinElmer) on the ChemiDoc Touch imaging system (Bio-Rad).
Proteomics and mass spectrometry. Cells extracts were prepared in Triton X-100 lysis buffer (20 mM Tris, pH 8.0, 137 mM NaCl, 10% glycerol, 0.2% Triton X-100, protease inhibitor cocktail (Calbiochem), 1 mM PMSF and 5 mM sodium orthovanadate) for 1 h on ice. Lysates were cleared by centrifugation for 10 min at 13,200 r.p.m. ELMO1 was immunoprecipitated using the mouse anti-ELMO1 monoclonal antibody 17 , and immunocomplexes were washed and subjected to SDS-PAGE. The gels were stained with SimplyBlue Safe stain (Invitrogen) and were destained with water. The gel bands were excised and frozen at -80 °C. After drying in a vacuum centrifuge, the gel bands were digested with 100 μ l of trypsin (Promega) (20 μ g ml -1 ) at 37 °C for 16 h. The digested peptides were extracted with 100 μ l 70% acetonitrile, 5% formic acid in a sonication bath. Each peptide sample was dried in a vacuum centrifuge and resuspended in 16 μ l 0.1% TFA. Each gel band digest was analyzed by nanoflow liquid chromatography (Easy-nLC1000, Thermo Fisher Scientific) coupled online with an Orbitrap Fusion Lumos Tribrid mass spectrometer (MS) (Thermo Fisher Scientific), samples were loaded on a C18 nano trap column, (Acclaim PepMap100 C18, 2 cm, nanoViper, Thermo Scientific) and resolved on a C18 Easy-Spray column (Acclaim PepMap RSLC C18, 2 μ m, 100 Å, 75 μ m × 500 mm, nanoViper, Thermo Scientific) with a linear gradient of 2% mobile phase B (95 % acetonitrile with 0.1% formic acid) to 32% mobile phase B within 60 min at a constant flow rate of 250 nl min -1 . The C18 Easy-Spray column was heated at 50 °C during the analysis. The most intense molecular ions in each MS scan within 3 s were sequentially selected for highenergy collisional dissociation using a normalized collision energy of 35%. The mass spectra were acquired at the mass range of m/z 400-1,600. The Easy-Spray ion source (Thermo Scientific) capillary voltage and temperature were set at 1.9 kV and 275 °C, respectively. Dynamic exclusion (30 s) was enabled during the MS/MS data acquisition to minimize redundant peptide fragmentation events. The radiofrequency lens was set to 30% during the MS analysis and both MS1 and MS2 spectra were collected in profile mode. Data was searched against a Swiss-Prot human protein database (http://www.uniprot.org/uniprot/) using Proteome Discoverer (v.2.1.1.21, Thermo Fisher Scientific) via Mascot (v. 2.5.1, Matrix Science Inc.) with the automatic decoy search option set followed by falsediscovery rate processing by Percolator. Data were searched with a precursor mass tolerance of 10 ppm and a fragment ion tolerance of 0.05 Da, a maximum of two tryptic miscleavages and dynamic modifications for oxidation (15.9949 Da) on methionine residues. Resulting peptide spectral matches were filtered using a false-discovery rate of ≤ 1% (Percolator q value ≤ 0.01). For determination of cell type-specific ELMO1 protein partners, only proteins that were present in all runs were analyzed. We calculated the normalized ratio of the Elmo1 -/spectral counts (Elmo1 -/-/Elmo1 +/+ + Elmo1 -/-). This calculation gives a value ranging from 0 to 1 with defined properties, where anything below 0.5 indicates a protein present in Elmo1 +/+ cells but lost in Elmo1 -/cells. We considered values at least one standard deviation and twofold decreased (for example, values less than 0.36) to be meaningful ELMO1 binding partners. Cross-comparison of normalized ratios afforded us the ability to then cross-compare ELMO1 binding partners between cell types. Neutrophil-specific ELMO1 partners identified in this study have a range of distinct functions [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] , and several have known associations with human arthritis 36, [73] [74] [75] [76] [77] [78] [79] [80] [81] .
IVIS Imaging. At the indicated time points during K/BxN serum transfer-induced arthritis, mice were anesthetized using isoflurane, injected intraperitoneally with 200 μ l of 50 mg ml -1 luminol (Sigma) in sterile saline solution, and scanned/analyzed using the IVIS Spectrum (PerkinElmer), following the manufacturer's instructions.
RNA-sequencing analysis. Neutrophils were purified from the bone marrow using anti-Ly6G, as described above. Peritoneal macrophages were prepared as described above. Total RNA was extracted and an mRNA library was prepared using Illumina TruSeq platform, followed by transcriptome sequencing using an Illumina NextSeq 500 cartridge. Cultures from four mice per group were sequenced. The statistical software package R (version 3.3.2) was used for all analyses. The Bioconductor package DESeq2 was used for differential gene expression analysis of RNAsequencing data. Heatmaps of neutrophil-specific Elmo1-dependent genes with associations to human arthritis [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] were created using the R package gplots via the heatmap.2 package.
Genome-wide association studies and experimental linkage analysis. We searched publicly available genome-wide association studies of human disease for SNP by gene interactions. The list of curated databases of published studies that were used is summarized in Supplementary Table 1 . Significance of a given SNP was determined in the original study. SNP by phenotype interactions were determined using the GWASdb SNP-phenotype association database. The data are plotted using a standardized P value as reported 95 . For determination of experimental linkage, a search of curated databases such as the DISEASES experimental gene-disease association database was performed (Supplementary Table 1 ). Significance of the experimental linkage association was determined via a previously established aggregated score [96] [97] [98] [99] [100] .
Statistical analysis. Statistical significance was determined using GraphPad Prism 5 or 6 using unpaired Student's two-tailed t-test or two-way analysis of variance. Variance was similar between groups. No inclusion/exclusion criteria were preestablished. A P value of < 0.05 (indicated by one asterisk), < 0.01 (indicated by two asterisks), < 0.001 (indicated by three asterisks), or< 0.0001 (indicated by four asterisks) was considered significant. Details are available in the Nature Research Reporting Summary.
